Whitepaper

The Changing face of Consumer Healthcare during COVID-19
Resetting the Consumer Healthcare market for the new normal
Consumer Healthcare during COVID-19

More Whitepapers / Newsletters

Lyme Disease Market
Lyme Disease

Lyme disease is a vector-borne infectious disease that spreads primarily by the bite of a tick (also known as Ixodes scapularis). It is quite a common disease, and poses a huge economic burden to glob...

Fibrodysplasia Ossificans Progressiva Newsletter
Fibrodysplasia Ossificans Prog...

Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification of the connective tissues and muscle tissues, such as ligaments and tendons. They are replaced by bo...

Induced Pluripotent Stem Cells (IPSCs) Research And Development
Induced Pluripotent Stem Cells...

IPSCs have enormous applications in the field of regenerative medicine, disease modelling, and drug discovery. For the development of regenerative medicine, somatic cells from a diseased patient are u...

Celiac disease Market
Celiac disease

Celiac disease is an autoimmune disorder against the gluten consumed that creates toxins, thereby, destroying the villi. It affects almost 1 percent of the population worldwide. Gain rich insights int...

Rethinking medtech in Covid times
Rethinking medtech in Covid ti...

COVID-19 transforms healthcare facets at an unprecedented pace. Based on emerging technology, we can be reasonably sure that the bulk of the change will be powered by the digital transformation made p...